Lidocaine for Status Epilepticus in Pediatrics.

about

Management of Status Epilepticus in Children Interactions of Mexiletine with Novel Antiepileptic Drugs in the Maximal Electroshock Test in Mice: An Isobolographic Analysis

P2860

Q26752721-8771D207-D6F5-479A-A46B-601003A010E0 Q58772300-8DBE1FCE-47BE-43C0-BFB4-EC7C9FB0914A

P2860

Lidocaine for Status Epilepticus in Pediatrics.

Item

http://www.wikidata.org/entity/Q35754082

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Lidocaine for Status Epilepticus in Pediatrics.

@ast

Lidocaine for Status Epilepticus in Pediatrics.

@en

type

Item

label

Lidocaine for Status Epilepticus in Pediatrics.

@ast

Lidocaine for Status Epilepticus in Pediatrics.

@en

prefLabel

Lidocaine for Status Epilepticus in Pediatrics.

@ast

Lidocaine for Status Epilepticus in Pediatrics.

@en

P1476

Lidocaine for Status Epilepticus in Pediatrics

@en

P2093

Colin J Kazina

http://www.w3.org/2001/XMLSchema#string

Frederick A Zeiler

http://www.w3.org/2001/XMLSchema#string

Kaitlin J Zeiler

http://www.w3.org/2001/XMLSchema#string

Lawrence M Gillman

http://www.w3.org/2001/XMLSchema#string

Michael West

http://www.w3.org/2001/XMLSchema#string

P2860

What is "quality of evidence" and why is it important to clinicians?

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

Gaps and opportunities in refractory status epilepticus research in children: a multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG).

The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit.

Lidocaine, carbamazepine, and imipramine have partially overlapping binding sites and additive inhibitory effect on neuronal Na+ channels.

Going from evidence to recommendations.

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.

Incorporating considerations of resources use into grading recommendations.

P304

414-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/CJN.2015.278

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeanne Teitelbaum

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281311868

http://www.w3.org/2001/XMLSchema#string

P698

26303341

http://www.w3.org/2001/XMLSchema#string

P921

lidocaine

status epilepticus

Lidocaine for Status Epilepticus in Pediatrics.

about

P2860

P2860

Lidocaine for Status Epilepticus in Pediatrics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921